Digital Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Application, By End-Use, By Regions; Segment Forecast, 2021

The global digital therapeutics market size is expected to reach USD 13.51 billion by 2028 according to a new study. The report “Global Digital Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Application (Diabetes, Obesity, CVD, CNS Disease, Respiratory Diseases, Smoking Cessation, Others), By End-Use (Patients, Providers, Payers, Employers, Others), By Regions; Segment Forecast, 2021 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The distinction between digital therapeutics is determined by patient clinical outcomes. Digital therapeutics do not use market-based health-related instruments like step and calorie-counters. It is a modern form of healthcare product that utilizes digital technologies to avoid, handle, and health ailments. Furthermore, it makes use of emerging health technology to treat the psychiatric ailment. As a result, the aforementioned factors contribute to the growth of the target market share.

During the year 2020, digital health went from innovation to need. As acceptance peaked, exacerbated by the COVID-19 pandemic, it swept into almost every healthcare domain. Telehealth, digital pathology, triage solutions, telemedicine, mhealth, and digital therapeutics were among the topics disc- U.Sed.

Omada Health, Inc., took advantage of the shortages in treatment caused by COVID-19 to offer additional help and advice through its dedicated practitioners to those whose doctor’s appointments had been postponed indefinitely.

Additionally, the organization assisted primary care practitioners, psychiatrists, endocrinologists, and cardiologists in converting their practices to telehealth through providing improved knowledge, psychosocial support, and an online platform.

Market participants such as 2Morrow, Inc., Akili Interactive Labs, Ayogo Health Inc., Better Therapeutics, Inc., Canary Health Inc., Click Therapeutics, Inc., Cognoa, Inc., Ginger, Kaia Health Software GmbH, Livongo Health Inc, Mango Health, Inc., Mindstrong Inc., Noom Health, Inc., Omada Health, Inc., Otsuka America Pharmaceutical, Inc., Pear Therapeutics, Inc., Propeller Health, WellDoc, Inc., and Wellthy Therapeutics are some of the companies operating in the market for digital therapeutics.

The FDA issued recommendations extending and encouraging the scope of digital health therapeutics technologies for mental health iss- U.S in response to COVID-19 and its ramifications on mental health. Another factor expected to drive demand growth is increased public and private sector initiatives. For example, Akili Interactive Labs, Inc. obtained the CE mark for EndeavorRx, its digital therapeutics software for the treatment of ADHD, in June 2020.

Digital therapeutics is anticipated to rise at a steady pace in the given timeframe, due to strong internet usage and reliance on smartphones. This is due to a rise in demand for creative and innovative treatment solutions that patients can access remotely.

In February 2021, SilverCloud and Cerner Corporation collaborated to combine SilverCloud’s virtual mental health network with Cerner’s electronic health records. SilverCloud hoped that by doing so, it would be able to scale the delivery of evidence-based mental health services while both enhancing patient outcomes and lowering healthcare costs.

The publisher has segmented the digital therapeutics market report based on application, end-use, and region:

Digital Therapeutics, Application Outlook (Revenue - USD Billion, 2016 - 2028)

Diabetes
Obesity
CVD
CNS Disease
Respiratory Diseases
Smoking Cessation
Others

Digital Therapeutics, End-Use Outlook (Revenue - USD Billion, 2016 - 2028)

Patients
Providers
Payers
Employers
Others

Digital Therapeutics, Regional Outlook (Revenue - USD Billion, 2016 - 2028)

North America
U.S
Canada
Europe
France
Germany
UK
Italy
Spain
Netherlands
Austria
Asia Pacific
China
India
Japan
Malaysia
South Korea
Indonesia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa

Frequently Asked Questions about the Digital Therapeutics Market

What is the estimated value of the Digital Therapeutics Market?

The Digital Therapeutics Market was estimated to be valued at $2.18 Billion in 2021.

What is the growth rate of the Digital Therapeutics Market?

The growth rate of the Digital Therapeutics Market is 29.8%, with an estimated value of $13.51 Billion by 2028.

What is the forecasted size of the Digital Therapeutics Market?

The Digital Therapeutics Market is estimated to be worth $13.51 Billion by 2028.

Who are the key companies in the Digital Therapeutics Market?

Key companies in the Digital Therapeutics Market include Proteus Digital Health Inc., Fitbit Inc., Pear Therapeutics Inc., Kaia Health, Happify Inc., Medtronic Plc., Omada Health Inc., Livongo Health Inc. and Resmed Inc..

Report Attribute	Details
No. of Pages	107
Published	May 2021
Forecast Period	2021 - 2028
Estimated Market Value ( USD ) in 2021	$ 2.18 Billion
Forecasted Market Value ( USD ) by 2028	$ 13.51 Billion
Compound Annual Growth Rate	29.8%
Regions Covered	Global
No. of Companies Mentioned	11

1. Introduction

1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
Secondary Sources

4. Digital Therapeutics Market Insights

4.1. Digital Therapeutics - Industry snapshot
4.2. Digital Therapeutics Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Constantly evolving digital healthcare infrastructure
4.2.1.2. Government sponsored initiatives
4.2.2. Restraints and Challenges
4.2.2.1. High upfront costs
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTLE Analysis
4.5. Digital Therapeutics Market Industry trends
4.6. COVID-19 Impact Analysis

5. Digital Therapeutics Market Assessment by Application

5.1. Key Findings
5.2. Introduction
5.2.1. Global Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
5.3. Diabetes
5.3.1. Global Digital Therapeutics Market, by Diabetes, by Region, 2016 - 2028 (USD Million)
5.4. Obesity
5.4.1. Global Digital Therapeutics Market, by Obesity, by Region, 2016 - 2028 (USD Million)
5.5. CVD
5.5.1. Global Digital Therapeutics Market, by CVD, by Region, 2016 - 2028 (USD Million)
5.6. CNS Disease
5.6.1. Global Digital Therapeutics Market, by CNS Disease, by Region, 2016 - 2028 (USD Million)
5.7. Respiratory Diseases
5.7.1. Global Digital Therapeutics Market, by Respiratory Diseases, by Region, 2016 - 2028 (USD Million)
5.8. Smoking Cessation
5.8.1. Global Digital Therapeutics Market, by Smoking Cessation, by Region, 2016 - 2028 (USD Million)

6. Global Digital Therapeutics Market, by End Use

6.1. Key Findings
6.2. Introduction
6.2.1. Global Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
6.3. Patients
6.3.1. Global Digital Therapeutics Market, by Patients, By Region, 2016 - 2028 (USD Million)
6.4. Providers
6.4.1. Global Digital Therapeutics Market, by Providers, by Region, 2016 - 2028 (USD Million)
6.5. Payers
6.5.1. Global Digital Therapeutics Market, by Payers, by Region, 2016 - 2028 (USD Million)
6.6. Employers
6.6.1. Global Digital Therapeutics Market, by Employers, by Region, 2016 - 2028 (USD Million)
6.7. Others
6.7.1. Global Digital Therapeutics Market, by Others, by Region, 2016 - 2028 (USD Million)

7. Digital Therapeutics Market Assessment by Geography

7.1. Key findings
7.2. Introduction
7.2.1. Digital Therapeutics Market Assessment, By Geography, 2016 - 2028 (USD Million)
7.3. Digital Therapeutics Market - North America
7.3.1. North America: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
7.3.2. North America: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
7.3.3. Digital Therapeutics Market - U.S.
7.3.3.1. U.S.: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
7.3.3.2. U.S.: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
7.3.4. Digital Therapeutics Market - Canada
7.3.4.1. Canada: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
7.3.4.2. Canada.: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
7.4. Digital Therapeutics Market - Europe
7.4.1. Europe: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
7.4.2. Europe: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
7.4.3. Digital Therapeutics Market - UK
7.4.3.1. UK: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
7.4.3.2. UK: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
7.4.4. Digital Therapeutics Market - France
7.4.4.1. France: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
7.4.4.2. France: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
7.4.5. Digital Therapeutics Market - Germany
7.4.5.1. Germany: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
7.4.5.2. Germany: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
7.4.6. Digital Therapeutics Market - Italy
7.4.6.1. Italy: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
7.4.6.2. Italy: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
7.4.7. Digital Therapeutics Market - Spain
7.4.7.1. Spain: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
7.4.7.2. Spain: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
7.4.8. Digital Therapeutics Market - Netherlands
7.4.8.1. Netherlands: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
7.4.8.2. Netherlands: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
7.4.9. Digital Therapeutics Market - Austria
7.4.9.1. Austria: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
7.4.9.2. Austria: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
7.5. Digital Therapeutics Market - Asia-Pacific
7.5.1. Asia Pacific: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
7.5.2. Asia Pacific: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
7.5.3. Digital Therapeutics Market - China
7.5.3.1. China: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
7.5.3.2. China: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
7.5.4. Digital Therapeutics Market - India
7.5.4.1. India: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
7.5.4.2. India.: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
7.5.5. Digital Therapeutics Market - Malaysia
7.5.5.1. Malaysia: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
7.5.5.2. Malaysia: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
7.5.6. Digital Therapeutics Market - Japan
7.5.6.1. Japan: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
7.5.6.2. Japan: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
7.5.7. Digital Therapeutics Market - Indonesia
7.5.7.1. Indonesia: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
7.5.7.2. Indonesia: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
7.5.8. Digital Therapeutics Market - South Korea
7.5.8.1. South Korea: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
7.5.8.2. South Korea.: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
7.6. Digital Therapeutics Market - Middle East & Africa
7.6.1. Middle East & Africa: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
7.6.2. Middle East & Africa.: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
7.6.3. Digital Therapeutics Market - Saudi Arabia
7.6.3.1. Saudi Arabia: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
7.6.3.2. Saudi Arabia.: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
7.6.4. Digital Therapeutics Market - UAE
7.6.4.1. UAE: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
7.6.4.2. UAE: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
7.6.5. Digital Therapeutics Market - Israel
7.6.5.1. Israel: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
7.6.5.2. Israel: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
7.6.6. Digital Therapeutics Market - South Africa
7.6.6.1. South Africa: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
7.6.6.2. South Africa: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
7.7. Digital Therapeutics Market - Latin America
7.7.1. Latin America: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
7.7.2. Latin America: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
7.7.3. Digital Therapeutics Market - Mexico
7.7.3.1. Mexico: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
7.7.3.2. Mexico.: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
7.7.4. Digital Therapeutics Market - Brazil
7.7.4.1. Brazil: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
7.7.4.2. Brazil.: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
7.7.5. Digital Therapeutics Market - Argentina
7.7.5.1. Argentina: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
7.7.5.2. Argentina.: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)

8. Competitive Landscape

8.1. Expansion and Acquisition Analysis
8.1.1. Expansion
8.1.2. Acquisition
8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

9.1. 2Morrow, Inc.
9.1.1. Company Overview
9.1.2. Financial Performance
9.1.3. Product & Services Benchmarking
9.1.4. Recent Development
9.2. Akili Interactive Labs
9.2.1. Company Overview
9.2.2. Financial Performance
9.2.3. Product & Services Benchmarking
9.2.4. Recent Development
9.3. Ayogo Health Inc.
9.3.1. Company Overview
9.3.2. Financial Performance
9.3.3. Product & Services Benchmarking
9.3.4. Recent Development
9.4. Better Therapeutics, Inc.
9.4.1. Company Overview
9.4.2. Financial Performance
9.4.3. Product & Services Benchmarking
9.4.4. Recent Development
9.5. Canary Health Inc.
9.5.1. Company Overview
9.5.2. Financial Performance
9.5.3. Product & Services Benchmarking
9.5.4. Recent Development
9.6. Click Therapeutics, Inc.
9.6.1. Company Overview
9.6.2. Financial Performance
9.6.3. Product & Services Benchmarking
9.6.4. Recent Development
9.7. Cognoa, Inc.
9.7.1. Company Overview
9.7.2. Financial Performance
9.7.3. Product & Services Benchmarking
9.7.4. Recent Development
9.8. Ginger
9.8.1. Company Overview
9.8.2. Financial Performance
9.8.3. Product & Services Benchmarking
9.8.4. Recent Development
9.9. Kaia Health Software GmbH
9.9.1. Company Overview
9.9.2. Financial Performance
9.9.3. Product & Services Benchmarking
9.9.4. Recent Development
9.10. Livongo Health Inc
9.10.1. Company Overview
9.10.2. Financial Performance
9.10.3. Product & Services Benchmarking
9.10.4. Recent Development
9.11. Mango Health, Inc.
9.11.1. Company Overview
9.11.2. Financial Performance
9.11.3. Product & Services Benchmarking
9.11.4. Recent Development
9.12. Mindstrong Inc.
9.12.1. Company Overview
9.12.2. Financial Performance
9.12.3. Product & Services Benchmarking
9.12.4. Recent Development
9.13. Noom Health, Inc.
9.13.1. Company Overview
9.13.2. Financial Performance
9.13.3. Product & Services Benchmarking
9.13.4. Recent Development
9.14. Omada Health, Inc.
9.14.1. Company Overview
9.14.2. Financial Performance
9.14.3. Product & Services Benchmarking
9.14.4. Recent Development
9.15. Otsuka America Pharmaceutical, Inc.
9.15.1. Company Overview
9.15.2. Financial Performance
9.15.3. Product & Services Benchmarking
9.15.4. Recent Development
9.16. Pear Therapeutics, Inc.
9.16.1. Company Overview
9.16.2. Financial Performance
9.16.3. Product & Services Benchmarking
9.16.4. Recent Development
9.17. Propeller Health
9.17.1. Company Overview
9.17.2. Financial Performance
9.17.3. Product & Services Benchmarking
9.17.4. Recent Development
9.18. WellDoc, Inc.
9.18.1. Company Overview
9.18.2. Financial Performance
9.18.3. Product & Services Benchmarking
9.18.4. Recent Development
9.19. Wellthy Therapeutics
9.19.1. Company Overview
9.19.2. Financial Performance
9.19.3. Product & Services Benchmarking
9.19.4. Recent Development

List of Tables

Table 1. Global Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
Table 2. Global Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
Table 3. Digital Therapeutics Market Assessment, By Geography, 2016 - 2028 (USD Million)
Table 4. North America: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
Table 5. North America: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
Table 6. U.S.: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
Table 7. U.S.: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
Table 8. Canada: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
Table 9. Canada: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
Table 10. Europe: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
Table 11. Europe: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
Table 12. UK: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
Table 13. UK: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
Table 14. France: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
Table 15. France: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
Table 16. Germany: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
Table 17. Germany: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
Table 18. Italy: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
Table 19. Italy: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
Table 20. Spain: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
Table 21. Spain: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
Table 22. Netherlands: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
Table 23. Netherlands: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
Table 24. Austria: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
Table 25. Austria: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
Table 26. Asia Pacific: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
Table 27. Asia Pacific: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
Table 28. China: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
Table 29. China: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
Table 30. India: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
Table 31. India: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
Table 32. Malaysia: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
Table 33. Malaysia: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
Table 34. Japan: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
Table 35. Japan: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
Table 36. Indonesia: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
Table 37. Indonesia: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
Table 38. South Korea: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
Table 39. South Korea: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
Table 40. Middle East & Africa: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
Table 41. Middle East & Africa: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
Table 42. Saudi Arabia: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
Table 43. Saudi Arabia: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
Table 44. UAE: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
Table 45. UAE: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
Table 46. Israel: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
Table 47. Israel: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
Table 48. South Africa: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
Table 49. South Africa: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
Table 50. Latin America: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
Table 51. Latin America: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
Table 52. Mexico: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
Table 53. Mexico: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
Table 54. Brazil: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
Table 55. Brazil: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)
Table 56. Argentina: Digital Therapeutics Market, By Application, 2016 - 2028 (USD Million)
Table 57. Argentina: Digital Therapeutics Market, By End Use, 2016 - 2028 (USD Million)

List of Figures

Figure 1 Market Highlights (2020, Revenue)
Figure 2 Integrated Ecosystem
Figure 3 Research Methodology: Top Down & Bottom Up Approach
Figure 4 Market by Geography
Figure 5 Porter’s Five Forces
Figure 6 Market by Application
Figure 7 Global Digital Therapeutics Market, By Application, 2020 & 2028 (USD Million)
Figure 8 Market by End Use
Figure 9 Global Digital Therapeutics Market, By End Use, 2020 & 2028 (USD Million)
Figure 10 Digital Therapeutics Market Assessment, By Geography, 2016 - 2028 (USD Million)
Figure 11 Strategic Analysis - Digital Therapeutics Market

Companies Mentioned

Proteus Digital Health Inc.
Fitbit Inc.
Pear Therapeutics Inc.
Kaia Health
Happify Inc.
Medtronic Plc.
Omada Health Inc.
Livongo Health Inc.
Voluntis Inc.
Resmed Inc.
Welldoc Inc.

Digital Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Application, By End-Use, By Regions; Segment Forecast, 2021 - 2028

The publisher has segmented the digital therapeutics market report based on application, end-use, and region:

Digital Therapeutics, Application Outlook (Revenue - USD Billion, 2016 - 2028)

Digital Therapeutics, End-Use Outlook (Revenue - USD Billion, 2016 - 2028)

Digital Therapeutics, Regional Outlook (Revenue - USD Billion, 2016 - 2028)

What is the estimated value of the Digital Therapeutics Market?

What is the growth rate of the Digital Therapeutics Market?

What is the forecasted size of the Digital Therapeutics Market?

Who are the key companies in the Digital Therapeutics Market?

Table of Contents

Companies Mentioned

The publisher has segmented the digital therapeutics market report based on application, end-use, and region:

Digital Therapeutics, Application Outlook (Revenue - USD Billion, 2016 - 2028)

Digital Therapeutics, End-Use Outlook (Revenue - USD Billion, 2016 - 2028)

Digital Therapeutics, Regional Outlook (Revenue - USD Billion, 2016 - 2028)

What is the estimated value of the Digital Therapeutics Market?

What is the growth rate of the Digital Therapeutics Market?

What is the forecasted size of the Digital Therapeutics Market?

Who are the key companies in the Digital Therapeutics Market?

Table of Contents

Companies Mentioned

Related Topics

Related Reports

Digital Health Market: Focus on Digital Therapeutics, Distribution by Type of Solution, Type of Therapy, Purpose of Solution, Type of Business Model, Target Therapeutic Area and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035

Digital Therapeutics (DTx) Market by Application (Prediabetes, Nutrition, Care, Diabetes, CVD, CNS, CRD, MSD, GI, Substance Abuse, Rehabilitation), Sales Channel B2C (Patient, Caregiver), B2B ( Providers, Payer, Employer, Pharma) - Global Forecasts to 2027

Digital Therapeutic Devices Market Research Report by Product (Insulin Pumps, Pain Management Devices, and Rehabilitation Devices), Application, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

Digital Therapeutics Market Research Report by Indication, Component, Distribution, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

Digital Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027